Novo Integrated Sciences (NVOS)
(Delayed Data from NSDQ)
$0.25 USD
+0.01 (3.70%)
Updated Oct 4, 2024 03:59 PM ET
After-Market: $0.24 -0.01 (-3.85%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NVOS 0.25 +0.01(3.70%)
Will NVOS be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for NVOS based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for NVOS
Why Xperi Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Why Greenland Technologies Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Why Tellurian Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket
Novo Integrated Sciences GAAP EPS of -$0.74, revenue of $3.15M